Welcome to the ICCS Website
The fundamental goal of the ICCS is to improve the quality of life and the life expectancy for all growing individuals with deficient bladder function, expressed as problems of storage and evacuation of urine. ICCS intends to approach this goal by increasing knowledge in all aspects of this problem area.
Ospedale Bambino Gesù, Roma
Urology & Urodynamics
Meeting Info | +39.0523.338391
Abstract submission is now open till April 20, 2018 http://188.8.131.52/ABS_Login.asp?IDcommessa=F18001&Lang=EN
- Drugs for Continence
- Surgery for continence
- Urinary Tract Infections (UTI)
- Bowel and Bladder Disfunction
- Neurogenic Bladder & Bowel in Children & Adolescents
Workshops & Educational Courses
- Workshops on Urodynamics & on Urotherapy | 26 Sep 2018
- Bladder & Bowel Dysfunction in Children to Adulthood | 27 Sep 2018
The ICCS is an independent, nonprofit organisation aimed at the advancement of research and healthcare. The ICCS Board and associated experts get no payment for their work. The running costs of the ICCS are covered by membership fees and unconditional educational grants from the medical industry.
Foremost among the latter are presently two companies: Ferring Pharmaceuticals and Coloplast, the cooperation with which we hereby gratefully acknowledge. The cooperation is regulated by contracts guaranteeing the independence and protection of both parts, and all matters of common interest are handled by liaison committees, with members from the ICCS and the two companies.
The ICCS members of the ICCS-Ferring liaison committee are Janet Chase, Søren Rittig and Johan Vande Walle. The ICCS members of the ICCS-Coloplast liaison committee are Mario De Gennaro, Søren Rittig and Anka Nieuwhof-Leppink.